CN Patent

CN107787324B — 氨甲酰基氨基吡唑衍生物的制备方法

Assigned to Sandoz AG · Expires 2020-05-19 · 6y expired

What this patent protects

本发明涉及使用二乙酰氧基碘苯(PhI(OAc) 2 )和非亲核碱制备氨甲酰基氨基吡唑衍生物的方法。

USPTO Abstract

本发明涉及使用二乙酰氧基碘苯(PhI(OAc) 2 )和非亲核碱制备氨甲酰基氨基吡唑衍生物的方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN107787324B
Jurisdiction: CN
Classification: —
Expires: 2020-05-19
Drug substance claim: No
Drug product claim: No
Assignee: Sandoz AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.